Comparative analysis of US real-world dosing patterns and direct infusion-related costs for matched cohorts of rheumatoid arthritis patients treated with infliximab or intravenous golimumab. [electronic resource]
- ClinicoEconomics and outcomes research : CEOR 2019
- 99-110 p. digital